Mission statement · Company scope
“Our mission is to develop first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other rare disorders.”
In use2020 – now1 sighting
First seenMar 2020Added
Last seenMar 2020Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary)
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 26 words · reading grade 15.6
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.76
- Record
- st_485c98a23c4c9f95
- Classification confidence
- 0.85
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2020-03-27 · sec_sentence · 10-K · accession 0001104659-20-039272
View filing ↗0 to compareCompare